Transaction · 0001780088-26-000019

Ticho Barry

Ticho Barry, CMO, reported an open-market or private sale at Stoke Therapeutics, Inc. involving 242.000000 shares for an estimated $7857.28. Reported holdings after the transaction were 25655.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCMO
STOKStoke Therapeutics, Inc.
Filing timeAug 19
Trade dateAug 18, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$33.03
Pre-filing
1mo ago -12.0%1w ago -0.2%1d ago -2.7%
Returns since
7d +0.2%30d -6.5%90d -6.5%180d -6.5%1y -6.5%

STOK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
STOK since 2026-08-19Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001780088-26-000019
Common Stock
Transaction date
Aug 18, 2026
Filed Aug 19, 2026, 12:29 AM · 1d delay
Shares
242 sh
$3.24k per share
Estimated value
-$785k
Computed from shares × price
Holdings after
25.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF MEDICAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertake…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive.

  4. F4

    Each performance stock unit represents a right to receive one share of the Issuer's common stock.

  5. F5

    Achievement of this performance stock unit award was certified on August 14, 2025. Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on A…

Original filing · 0001780088-26-000019
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

STOK